BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9406825)

  • 1. Epidermal remodeling in psoriasis (II): a quantitative analysis of the epidermal architecture.
    Iizuka H; Honda H; Ishida-Yamamoto A
    J Invest Dermatol; 1997 Dec; 109(6):806-10. PubMed ID: 9406825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal remodelling in psoriasis (III): a hexagonally-arranged cylindrical papilla model reveals the nature of psoriatic architecture.
    Iizuka H; Honda H; Ishida-Yamamoto A
    J Dermatol Sci; 1999 Sep; 21(2):105-12. PubMed ID: 10511479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriatic architecture constructed by epidermal remodeling.
    Iizuka H; Takahashi H; Ishida-Yamamoto A
    J Dermatol Sci; 2004 Aug; 35(2):93-9. PubMed ID: 15265521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal remodelling in psoriasis.
    Iizuka H; Ishida-Yamamoto A; Honda H
    Br J Dermatol; 1996 Sep; 135(3):433-8. PubMed ID: 8949439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes.
    Piepkorn M; Predd H; Underwood R; Cook P
    Arch Dermatol Res; 2003 Jul; 295(3):93-101. PubMed ID: 12768307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histopathologic spectrum of psoriasis.
    Murphy M; Kerr P; Grant-Kels JM
    Clin Dermatol; 2007; 25(6):524-8. PubMed ID: 18021888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis: hyperproliferation cannot induce characteristic epidermal morphology.
    Heenen M; Galand P; de Maertelaer V; Heenen PH
    Cell Tissue Kinet; 1987 Nov; 20(6):561-70. PubMed ID: 3502926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution pattern of psoriatic keratoblasts: computer-assisted image-analysis for combined evaluation of DNA synthesis and expression of 67 kD keratin polypeptides in the epidermis of stable plaques of psoriasis.
    Van Neste DJ; Staquet MJ; Leroy BP; De Coster WJ
    J Invest Dermatol; 1988 Mar; 90(3):382-6. PubMed ID: 2450145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cell death and proliferation in psoriatic epidermis.
    Kawashima K; Doi H; Ito Y; Shibata MA; Yoshinaka R; Otsuki Y
    J Dermatol Sci; 2004 Sep; 35(3):207-14. PubMed ID: 15381242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Formation of dermo-epidermal hyperplasia in psoriasis].
    Pierard GE; Pierard-Franchimont C
    Ann Dermatol Venereol; 1983; 110(11):891-7. PubMed ID: 6666933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
    Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
    J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of epidermal nerve density and opioid receptor levels in psoriatic itch.
    Taneda K; Tominaga M; Negi O; Tengara S; Kamo A; Ogawa H; Takamori K
    Br J Dermatol; 2011 Aug; 165(2):277-84. PubMed ID: 21457210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis: the epidermal component.
    Tschachler E
    Clin Dermatol; 2007; 25(6):589-95. PubMed ID: 18021897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceramides and cell signaling molecules in psoriatic epidermis: reduced levels of ceramides, PKC-alpha, and JNK.
    Lew BL; Cho Y; Kim J; Sim WY; Kim NI
    J Korean Med Sci; 2006 Feb; 21(1):95-9. PubMed ID: 16479073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of interleukin-4 receptors on psoriatic epidermal cells.
    Prens E; Hegmans J; Lien RC; Debets R; Troost R; van Joost T; Benner R
    Am J Pathol; 1996 May; 148(5):1493-502. PubMed ID: 8623919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mathematical model of proliferative activity in epidermis of the normal skin and of the skin afflicted by psoriasis].
    Laptev MV; Nikulin NK
    Biofizika; 2003; 48(1):84-90. PubMed ID: 12630120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal architecture that depends on turnover time.
    Iizuka H
    J Dermatol Sci; 1995 Nov; 10(3):220-3. PubMed ID: 8593264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ; Seyger MM; Van de Kerkhof PC
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal kinetic alterations required to generate the psoriatic phenotype: a reappraisal.
    Simonart T; Heenen M; Lejeune O
    Cell Prolif; 2010 Jun; 43(3):321-5. PubMed ID: 20546247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.